As of July 7, 2017, pharmacies in West Virginia are required to report Gabapentin as a Drug of Concern to the state’s Controlled Substance Monitoring Program (CSMP).
News: Legal & Regulatory
Beginning August 9, 2017, Schedule V controlled substances must be reported to the Arizona Controlled Substances Prescription Monitoring Program (PMP), in addition to already reported Schedule II, III and IV drugs.
Effective Tuesday, August 15, 2017, the Colorado Prescription Drug Monitoring Program (CO PDMP) will change how prescription data submissions are reported by moving to Appriss® PMP AWARxE™.
In May, the Massachusetts Department of Public Health released a requirement that Gabapentin and its chemical equivalents be included as an "additional" Schedule VI drug for PMP reporting.
Under regulation § 1707.5, California is making changes to its label requirements for prescription drug containers dispensed to patients in the state.
Wisconsin Enhanced Prescription Drug Monitoring Program (WI ePDMP): New Data Submission Frequency and Data Fields
Effective Saturday, April 1, 2017, a new data submission and correction frequency is required by the Wisconsin Department of Safety and Professional Services (DSPS). Effective Sunday, April 9, 2017, the Wisconsin DSPS requires pharmacies to submit the names of persons picking up Schedule II or Schedule III prescriptions, unless an exception applies.
Effective immediately, according to legislation passed by the 2017 General Assembly (House Bill 2164) and signed into law by the governor, pharmacies must report prescriptions for Gabapentin, including all dispenses since the legislation was signed on February 23, 2017, to the VA PMP.
Effective Sunday, March 26, 2017, at 5 PM CDT, the Illinois Department of Healthcare and Family Services is implementing the Pharmacy Benefits Management System (PBMS). Pharmacies are required to submit claims to Illinois Medicaid using a new Bank Identification Number (BIN) and Processor Control Number (PCN).
Effective Tuesday, April 4, 2017, MI PMP will replace the Michigan Automated Prescription System (MAPS) with a new vendor, PMP AWARxE maintained by Appriss®, to provide prescription monitoring services.
Effective Wednesday, March 15, 2017, the Ohio Automated Rx Reporting System (OARRS) will change how prescription data submissions are reported by moving to the Appriss® PMP Clearinghouse.